These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Formulary system versus formulary, "the book". Habeger HE Am J Hosp Pharm; 1987 Sep; 44(9):2030. PubMed ID: 3674036 [No Abstract] [Full Text] [Related]
45. Is there a need for critical ethical and philosophical evaluation of hospital drugs and therapeutics (D&T) committees? Fijn R; van Epenhuysen LS; Peijnenburg AJ; Brouwers JR; de Jong-van den Berg LT Pharmacoepidemiol Drug Saf; 2002; 11(3):247-52. PubMed ID: 12058711 [No Abstract] [Full Text] [Related]
46. P & T Committee interview: Promoting rational drug use. Hunt TK; Herfindal ET Hosp Formul; 1988 Apr; 23(4):359-62, 365-6, 369. PubMed ID: 10286839 [TBL] [Abstract][Full Text] [Related]
47. Developing a quick reference formulary. Huntzinger PE Mil Med; 2001 Oct; 166(10):881-3. PubMed ID: 11603239 [TBL] [Abstract][Full Text] [Related]
48. Pharmaceuticals issue brief: managed care drug formularies: year end report-2002. Morgan R; MacEachern L Issue Brief Health Policy Track Serv; 2002 Dec; ():1-7. PubMed ID: 12856686 [TBL] [Abstract][Full Text] [Related]
50. Antisubstitution law changes and the hospital formulary system. Fink JL Am J Hosp Pharm; 1977 Jan; 34(1):90-3. PubMed ID: 831478 [TBL] [Abstract][Full Text] [Related]
51. Strengthening the formulary system by implementing a drug usage guidelines program. Huber SL; Patry RA; Hudson HD; Godwin HN Hosp Formul; 1984 Aug; 19(8):664-8. PubMed ID: 10267390 [TBL] [Abstract][Full Text] [Related]
52. A survey of drug formulary procedures in Naval Hospitals and the feasibility of change. Lucas JR; Winship HW Mil Med; 1976 Jan; 141(1):13-20. PubMed ID: 814484 [No Abstract] [Full Text] [Related]
53. How we make our hospital formulary work effectively. Burns D Pharm Times; 1985 Jun; 51(6):98, 100-1. PubMed ID: 10271653 [No Abstract] [Full Text] [Related]
56. P & T Committee interview: Establishing and maintaining a dynamic formulary. Rostand S; Lazarus H Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373 [TBL] [Abstract][Full Text] [Related]
57. Drug purchasing. Mehl B Hosp Pharm; 1988 Mar; 23(3):283-6. PubMed ID: 10318047 [No Abstract] [Full Text] [Related]
58. Assessment of patient satisfaction with a formulary switch from omeprazole to lansoprazole in gastroesophageal reflux disease maintenance therapy. Condra LJ; Morreale AP; Stolley SN; Marcus D Am J Manag Care; 1999 May; 5(5):631-8. PubMed ID: 10537869 [TBL] [Abstract][Full Text] [Related]
59. Physician satisfaction with formulary policies: is it access to formulary or nonformulary drugs that matters most? Glassman PA; Good CB; Kelley ME; Bradley M; Valentino M Am J Manag Care; 2004 Mar; 10(3):209-16. PubMed ID: 15032258 [TBL] [Abstract][Full Text] [Related]
60. Assessment of formulary development in a small hospital. Holt RT; Larson DS; Scheil ES Hosp Pharm; 1988 Jul; 23(7):649-52, 656, 666. PubMed ID: 10288268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]